INTRODUCING THE NEW METOJECT® PEN

Metoject® PEN is an autoinjector, pre-filled with methotrexate.

Metoject® PEN is indicated for:

  • Active rheumatoid arthritis
  • Severe, active juvenile idiopathic arthritis

5 available dosages with easy distinguishable colour-code-system

medac-Metoject-Pen-logo
New Metoject Pen

7.5mg
(0.15ml)

10mg
(0.2ml)

15mg
(0.3ml)

20mg
(0.3ml)

25mg
(0.5ml)

Refer My Patient

What is Metoject® PEN?

Metoject® PEN is a pre-filled autoinjector containing methotrexate (MTX) solution at a concentration of 50mg/ml.

Metoject® PEN is available in a variety of doses and your doctor will prescribe the correct one for you.

Metoject is a prescription-only medicine indicated for the treatment of:

  • Active rheumatoid arthritis in adult patients
  • Severe recalcitrant disabling psoriasis, which is not adequately responsive to other forms of therapy such as phototherapy, PUVA, and retinoids, and severe psoriatic arthritis in adult patients.
New Metoject Pen

Features of the Metoject® New PEN

2-step auto-injector without release button

Acoustic signal at beginning and end of injection

Inspection window to check complete injection

Larger labeling with colour code

Angular shape with anti-rolling-feature

Nurse training and sharps disposal service is available in the home. See  HOME SERVICES for more information

Patient Information Leaflet